Irbesartan Tablet
Product Images NDC 71335-2745

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 71335-2745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352745)

Label (Lbl713352745)
Each tablet contains 75 mg of Irbesartan, which is a medication used for conditions like high blood pressure. The tablets should be stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). It is essential to keep this and all drugs out of the reach of children. The package contains 30 tablets. More dosing information can be obtained by scanning the QR code on the package insert. The tablets are manufactured by Zhejiang Huahai Pharma Co. in partnership with Bryant Ranch Prepack, Inc.*
FDA Label Image

Structure (Spl Image1 Structure)

FDA Label Image

Figure 1 (Spl Image2 Figure1)

FDA Label Image

Figure 2 (Spl Image3 Figure2)

FDA Label Image

Figure 3 (Spl Image4 Figure3)

Figure 3 (Spl Image4 Figure3)
This text compares the effectiveness of three medications: Losartan, Amlodipine, and a placebo in treating a certain condition. The results show the relative risk reduction for Losartan versus placebo and Losartan versus Amlodipine over a follow-up period of 21 to 54 months. These results can provide valuable insights into the efficacy of these medications in managing the condition.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.